Medifast (MED) Tops Q4 EPS by 9c, Revenues Beat; Offers EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Medifast, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results
February 26, 2019 4:16 PM ESTBALTIMORE, Feb. 26, 2019 /PRNewswire/ --Â Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today reported financial results for the fourth quarter and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights:
Revenue of $145.8 million, an increase of 87.0% year-over-year Active earning Coaches of 24,100, an increase of 60.7% year-over-year Net income of $15.7 million, an increase of 114.2%... More